OBJECTIVES: This retrospective single-centre review presents mid-and long-term results of stented biological valves (SBVs) in the pulmonary position.
INTRODUCTION
Reconstruction of the right ventricular outflow tract (RVOT) for pulmonary regurgitation is commonly performed with a valved conduit. Cryopreserved pulmonary homografts have been considered the gold standard for RVOT reconstruction since the 1980s [1] [2] [3] , but tissue banks are not able to meet the increasing demand [4] . Therefore, valved conduits made of various materials have been introduced into the clinical routine [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] . In some cases, stented biological valves (SBVs) can be implanted directly into the native pulmonary artery or into a previously implanted conduit. However, just like homografts, all bioprostheses gradually degenerate, and valve failure due to calcification, immunological reactions and outgrowth is inevitable. Pulmonary stenosis and regurgitation followed by right ventricular dysfunction result, demanding intervention or surgical replacement of the valve [9, 10, 15, 16] .
In the light of the great diversity of valves, conduits and approaches, it is essential to evaluate implanted bioprostheses with respect to their haemodynamic qualities and properties that permit the postponement of reoperations and interventions. This study presents our institutional experience with SBVs for RVOT reconstruction over a 15-year period.
Patient characteristics
Between January 2000 and May 2015, 52 patients (29 men, 23 women) underwent RVOT reconstruction with SBVs at a single institution. The median age and the median body weight were 22.8 years (range 5-77 years) and 62 kg (range 14-110 kg) at the time of SBV implantation, respectively. Patient characteristics with original diagnoses and previous procedures are presented in Table 1 . The most frequent cardiac diagnosis was tetralogy of Fallot (50%). Forty-four patients (85%) had undergone cardiac surgery at least once (median 2; range 1-5 sternotomies). At the time of SBV implantation, 19 patients had transannular and 3 patients had only subvalvular RVOT patches (42%); 17 patients had a native RVOT with pulmonary valve remnants (33%); and 13 patients had biological valves or conduits (25%; 5 stented St. Jude Medical valves, St. Jude Medical, St Paul, MN, USA; 3 pulmonary homografts, 2 Contegra conduits, Medtronic, Inc., Minneapolis, MN, USA; 1 Hancock conduit, Medtronic, Inc.; 1 Shelhigh porcine valved conduit, Shelhigh, Inc., Millburn, NJ, USA; 1 valveless conduit).
Surgery
The operative details, including surgical indication, concomitant procedures, valve size distribution, valve types and operation times, are given in Table 2 .
The type of SBV was selected by the surgeon on the basis of his or her preference and on which valves were available. The implanted SBVs included 17 porcine Carpentier-Edwards Supraannular (Edwards Lifescience LLC, Irvine, CA, USA), 13 bovine Carpentier-Edwards Perimount (Edwards Lifescience LLC), 12 bovine St. Jude Medical Trifecta (St. Jude Medical, St. Paul, MN, USA), 4 bovine Sorin Mitroflow (Sorin Group, Milan, Italy), 4 bovine Sorin Soprano (Sorin Group) and 2 bovine Sorin More (Sorin Group). The median valve size was 23 mm (range 19-27 mm). Surgery was performed via a median sternotomy on an empty beating heart with cardiopulmonary bypass. In 16 patients, additional intracardiac lesions were addressed after aortic cross-clamping. All degenerated, previously implanted bioprostheses and calcified patch material were completely excised before SBV implantation. In 5 patients, the previously implanted conduits were left in place, and SBVs were inserted into them. The anterior incision was either closed directly (n = 6) or covered with a separate patch (Dacron, n = 20; autologous pericardium, n = 15; Gore-Tex, n = 1).
Since 2013, RVOT reconstruction in patients with huge pulmonary arteries was performed by creating self-tailored valved conduits from SBVs and Dacron tubes (n = 10). Before the skin incision, a 25-mm or 27-mm bovine pericardial Trifecta valve was sutured into a 3-mm larger Dacron graft sliced into halves with a running 5/0 polytetrafluoroethylene suture line. After trimming, the self-tailored valved conduit was placed between the pulmonary artery bifurcation and the RVOT using continuous sutures (Fig. 1) .
Follow-up
The mean follow-up time (100%) was 7.9 ± 5.5 years with a total of 409 patient-years. Patients' postoperative data were collected from our institute, cooperating hospitals and patients' local cardiologists. Follow-up included physical examination and echocardiograms of all patients, magnetic resonance imaging and intracardiac catheter examination in a few cases. Peak pressure gradients were calculated in mmHg by measuring the velocity at the subvalvular, valvular and supravalvular levels. Pulmonary regurgitation was evaluated and classified as none, mild (regurgitation jet restricted to the RVOT) or moderate (regurgitation jet reaching into the ventricular body), or severe (backflow starting from the level of the pulmonary artery bifurcation or further distally). Valve degeneration was defined as a valvular peak pressure gradient >50 mmHg or pulmonary valve regurgitation more than moderate. Valve replacement was defined as surgical or interventional valve replacement due to (i) pulmonary valve degeneration as defined above; (ii) endocarditis or (iii) right ventricular dysfunction. Cases with only moderate degeneration but with valve replacement in the context of another inevitable cardiac operation have been statistically censored.
Statistical analysis
Data collection was performed retrospectively. Categorical data were expressed in numbers and percentages; continuous data were expressed in mean values with standard deviation or in median values with range according to the distribution. The obtained pulmonary pressure gradients and regurgitation grades were analysed at cross-sectional intervals. Peak pressure gradients over porcine and bovine SBVs were compared using non-parametric Wilcoxon tests. Freedom from postoperative events was analysed according to the Kaplan-Meier method with a 95% confidence interval (CI). Analysis of risk factors for the end-point 'valve degeneration' was carried out in a two-step approach. In a first step, univariate analysis was performed by log-rank testing for categorical variables and by applying Cox proportional hazard models for continuous variables. We analysed the influence of age, weight, gender, cardiac diagnosis, surgical indication, number of previous RVOT operations, presence of previous bioprostheses, type of SBV, surgical technique of SBV implantation (RVOT patch/direct/conduit), size and material of the SBV (porcine/bovine), and operation times. For better interpretation, continuous variables were dichotomized at their optimal cut-off levels on the basis of the maximally selected rank. In a second step, variables that reached a P-value <0.2 were included in a multivariate analysis, applying a multivariable Cox model. All statistical analyses were conducted using the software R version 3.3.0 (R Foundation for Statistical Computing, Vienna, Austria). Statistical significance was defined as a P-value of <0.05.
RESULTS

Survival
Two patients died 5.8 and 6.1 years after SBV implantation at the ages of 77 and 73 years, respectively. None of the deaths was associated with RVOT surgery, failure of the pulmonary valve, RVOT or pulmonary artery intervention. Causes of death were traumatic subarachnoid haemorrhage (no anticoagulation therapy) and hepatic metastatic carcinoid syndrome, respectively.
Valve degeneration
In all patients, the mean value of the peak pressure gradients over the SBVs increased from 23 ± 14 mmHg early in the postoperative period to 38 ± 30 mmHg at the last follow-up. Twelve SBVs (23%) were identified as degenerated after a mean follow-up of 4.1 ± 3.3 years. The rates of freedom from valve degeneration were 92% (CI 82-97), 84% (CI 70-92), 66% (CI 48-80) and 66% (CI 48-80) after 1, 5, 10 and 15 years, respectively. All degenerated valves showed isolated pulmonary stenosis. The mean peak pressure gradient over stenotic SBVs was 79 ± 35 mmHg. Peak gradients were Pulmonary peak pressure gradients. Significantly higher peak pressure gradients over porcine than over bovine stented biological valves (SBVs) postoperatively and at the last follow-up assessment; the line at 50 mmHg marks the defined threshold value for pulmonary stenosis.
significantly higher over the porcine than over the bovine valves, both post-operation (P < 0.001) and at the individual last follow-up (P = 0.001, Fig. 2 ). Regurgitation grades tended to increase over time (Fig. 3) . At the last follow-up assessment, regurgitation was graded as none (n = 20), mild (n = 15) and moderate (n = 17); severe regurgitation did not occur.
Valve replacement
Valve replacement including surgery and intervention was performed in 11 patients (21%) after a mean duration of 9.0 ± 4.1 years due to pulonary stenosis (n = 8), endocarditis (n = 2) or clinical signs of right ventricular dysfunction (n = 1). The rates of freedom from valve replacement were 100%, 92% (CI 79-97), 81% (CI 64-91) and 60% (CI 40-78) after 1, 5, 10 and 15 years, respectively.
Risk analysis
Univariate analysis (Table 3) identified younger patient age at SBV implantation (P = 0.025) as a significant risk factor for valve degeneration. Additionally, using optimal cut-off values of dichotomized variables, patient age <19.1 years (P = 0.002, Fig. 4 ), previous RVOT surgery ≤1 (P = 0.001) and total operation time > 270 min (P = 0.001) were considered statistically significant. Subsequent multivariate analysis confirmed patient age <19.1 years as the only significant risk factor for valve degeneration (P = 0.007).
Transcatheter pulmonary valve replacement
The implantation of a transcatheter valve-in-valve (Melody transcatheter pulmonary valve, Medtronic, Inc.) avoided reoperation in five adult patients, all older than 19.1 years. Thus, the rate of freedom from surgical valve replacement for this age group was 100% (Fig. 5) .
DISCUSSION
The choice of material used for RVOT reconstruction should be based on durability and availability, but diversity of cardiac bioprostheses has grown in the last decades. In this study, the performance of 52 stented biological valves (SBVs) implanted between 2000 and 2015 was retrospectively analysed. Especially after implantation in adult patients who required pulmonary valve replacement following several RVOT operations, SBVs offered encouraging long-term durability and the possibility of transcatheter valve implantation.
Valve degeneration
Pulmonary stenosis was identified as the main reason for reoperation and intervention, a finding that was similar to that with pulmonary valved conduits [7, 11, 17] . Accordingly, the failure of stented porcine and bovine valves in the pulmonary position [5, 17] was attributed to leaflet sclerosis and calcification. We did not observe neointimal peel formation [18] or supravalvular obstruction at the distal conduit anastomosis, which occurred in Contegra, Shelhigh and Matrix P plus conduits [10, 12, 13] . In addition, none of the SBVs showed evidence of severe pulmonary regurgitation during follow-up visits. The reinforcement of the valve by the stented design certainly prevents valve dilatation and hence, pulmonary regurgitation, which could be a considerable advantage compared with homografts and stentless bioprostheses. The development of pulmonary peak pressure gradients in the entire cohort and over stenotic SBVs corresponds to results from other RVOT studies. First, the mean systolic peak gradient over all SBVs increased by 15 ± 22 mmHg during a mean follow-up of almost 8 years. Accordingly, Ruzmetov et al. reported an increase of mean peak pressure gradients over stented bovine pericardial valves from 12 ± 10 mmHg postoperatively to 22 ± 7 mmHg during the 4-year mean follow-up period [14] . Second, the mean systolic peak gradient across the stenotic SBVs was 80 ± 34 mmHg, which corresponds to previously reported gradients of 63 ± 13 mmHg over stenotic stented bioprosthic valves [19] or 87 ± 11 mmHg over stenotic Hancock conduits [11] . In addition, we observed significantly higher pressure gradients across porcine compared with bovine valves. This materialdependent effect is well known and is not a sign of earlier calcification or deterioration [20] .
Valve replacement
Pulmonary homografts as the gold standard for RVOT reconstruction and various other porcine valved or bovine jugular vein conduits have been reported with a durability of 55-90% during midand long-term follow-up [3, 6, 11, 16, 17, 21] . The rates of freedom from valve replacement in this study-including both surgical and interventional-were 92, 81 and 60% after 5, 10 and 15 years, respectively. These values are comparable to those from several studies with adult patients and older children after pulmonary valve replacement. Ruzmetov et al. implanted stented bovine pericardial valves in 49 patients (median age 22.4 years; range 5-50 years) and reported 94% freedom from RVOT reintervention and 98% freedom from bioprosthetic explantation after 10 years. The 'partly oversized' large valve sizes in their series (21-33 mm) may have contributed to the superior durability of the valves [14] . Jang et al. described patients who, after repair of tetralogy of Fallot, underwent valve replacement with different stented valves. Their rate of freedom from reoperation after 10 years was 66% [19] . Lee et al. compared the performance of three types of bioprostheses (stented porcine, stented bovine pericardial and stentless porcine valves). The 10-year rate of freedom from reoperation was 85% for stented bovine pericardial and 49% for stented porcine valves. Stentless valves were shown to be significantly inferior, with only 31% freedom from reoperation after 10 years, explained by a lower mean age and smaller valve size [15] . Correspondingly, we could not identify any differences between the the durability of SBVs with bovine pericardial or porcine leaflets. However, considering that the pressure gradient increased faster in the latter group, it remains to be considered whether bovine valves should be preferred over porcine ones.
Some patients in our series had peak pressure gradients slightly above 50 mmHg but had not yet had valve replacement. According to our definition, they were considered to have valve degeneration but because they maintained consistent peak gradients 50 mmHg over the years, valve replacement was postponed. This approach is permitted if the patients are followed up frequently. For this reason, freedom from valve replacement was lower than that from valve degeneration at the 15-year follow-up.
Risk factors
Results after implantation depend on several factors such as the diagnosis, age, anatomy and size of the RVOT and pulmonary trunk and peripheral artery size [5, 9] . In this study, younger age at SBV implantation was a significant risk factor for valve degeneration. The influence of the patient's age on the durability of the valve is confirmed by almost all publications about valves and conduits for pulmonary valve replacement and RVOT reconstruction [3, 5, 6, 11, 13, 15, 16, 19, 21] . Possible causes for early valve failure in younger patients are increased immunological reactions, higher calcium turnover and higher pressures generated in the right ventricle, but the exact pathomechanisms remain unknown [15] . A large number of publications also declare small valve size as a significant risk factor for prosthesis failure because the patient outgrows the valve [3, 5, 6, 13, 16, 17] .
It has to be taken into account that the age at implantation and the size of the valve are commonly positively correlated. In our risk factor analysis, however, we found only a significant effect of the age at implantation, not of valve size, indicating the use of oversized valves in smaller patients. A correlation between early graft failure and valve oversizing has been reported [22] .
In addition, the univariate analysis showed a significantly better outcome for patients with a higher number of previous RVOT operations. It seems to be paradox and contradicts the results of Stark et al. [23] , who reported shorter freedom from valve failure in patients with second and subsequent conduit implantations. The explanation certainly lies in the predominant protective influence of older age, which is obviously associated with higher number of reoperations.
'Self-tailored' conduit Allen et al. presented 100% freedom from explantation and intervention after 7 years of follow-up using a technique for RVOT reconstruction with a self-made valved conduit [8] . They fashioned a tube from a flat sheet of Gore-Tex, sutured the posterior portion of the distal and proximal anastomoses, inserted a Carpentier-Edwards pericaridal valve in the central position and completed the anterior portion of the anastomosis. As an alterantive method in patients with dilated pulmonary arteries, we currently tailor a bovine pericardial Trifecta valve into a horizontally opened Dacron tube before skin incision. During preoperative assessment, careful measurement of the pulmonary artery bifurcation by magnetic resonance imaging is necessary. This method precludes tilting of the SBV during implantation with a patch covering.
Transcatheter pulmonary valve replacement
The stented design provides the interventionist with a defined 'landing zone' for percutaneous valve implantation. Since its introduction at our institution in 2009, five adult patients were treated successfully using the Melody transcatheter pulmonary valve. The performance of implanted Melody valves has been excellent; no stent fractures have occurred and no reinterventions or explantations have had to be performed, and no patient older than 19.1 years required reoperation. Current reports on the transcatheter valve implantation technique in the pulmonary position are encouraging, and include low procedure-related complications, low morbidity and mortality rates, improvements in haemodynamics and valvular function, and the possibility of further interventional valve-in-valve implantations [24, 25] . Finch et al. even called bioprostheses 'ideal substrates' for interventional pulmonary valve replacement [24] . Thus, the demand for surgical valve replacement can be delayed by inserting one or more Melody valves. By initially implanting valves with larger diameters, one can delay reoperation to a late stage through the use of multiple transcatheter valve-in-valve procedures, which will be the focus of further investigation.
Limitations
The limitations of this study include the retrospective singlecentre studies design with a relatively small and heterogenous patient population.
CONCLUSION
The use of SBVs for RVOT reconstruction has several advantages particularly in adult patients in whom freedom from surgical valve replacement is excellent. It offers a wide choice of valves, especially larger ones, and of implantation techniques. First, SBVs can be inserted directly into the native pulmonary artery or a pre-existing conduit; second, they can be combined with transannular RVOT patch augmentation; and third, they can be used to construct a self-tailored valved conduit. Finally, the incorporated stent protects the SBV against valvular dilatation and regurgitation and creates a defined, supported landing zone for future interventional valve-in-valve implants.
